Returns
Growth option. Annualised, to 09 Oct 2026.
| 1 year | 3 years | 5 years | |
|---|---|---|---|
| Direct plan | 8.0% | n/a | n/a |
| Regular plan | 6.2% | n/a | n/a |
Baroda BNP Paribas Health and Wellness Fund Direct Growth NAV on 09 Oct 2026: ₹10.4898. Regular Growth NAV: ₹10.2612. A fund's NAV already has its costs taken out, so these are the returns an investor received, before tax.
Baroda BNP Paribas Health and Wellness Fund is a sectoral and thematic fund.
Direct plan against regular plan
Both plans hold the same portfolio. Over 1 year, the direct plan returned 8.0% and the regular plan 6.2%. The difference of 1.79% is mostly the commission the regular plan pays a distributor.
See what that costs over timeWhy there is no ranking here
Sector and theme funds are not ranked against each other here, because each follows a different slice of the market. A sector or theme fund is a bet on one part of the economy. Look at how large a part of your portfolio it is, and what would have to go right for it to pay off.
Check your whole portfolio
One fund says little on its own. Add everything you hold to see what you pay in commissions, which funds double up and where the portfolio is lopsided.
Check your portfolioTalk it through first
Whether a fund belongs in your portfolio depends on your goals, your tax position and what else you own. An advisor will go through it with you on a free call.
Talk to an advisorTop holdings of Baroda BNP Paribas Health and Wellness Fund
The ten largest of its 33 shares, as the fund last disclosed them. Together they are 58% of the fund.
| Company | Sector | Part of the fund |
|---|---|---|
| Sun Pharma.Inds. | Pharmaceuticals | 8.6% |
| Torrent Pharma. | Pharmaceuticals | 7.9% |
| Divi's Lab. | Pharmaceuticals | 7.8% |
| Ipca Labs. | Pharmaceuticals | 6.1% |
| Laurus Labs | Pharmaceuticals | 6.1% |
| Lupin | Pharmaceuticals | 5.8% |
| Apollo Hospitals | Healthcare | 5.3% |
| Fortis Health. | Healthcare | 4.0% |
| Dr Lal Pathlabs | Healthcare | 3.5% |
| Mankind Pharma | Pharmaceuticals | 3.3% |
Largest sectors
Where the fund's equity money sits.
Holdings change every month. If you hold more than one fund, the portfolio check shows how much of the same shares they hold.
Other sectoral and thematic funds
The 223 funds in this category with at least a year behind them. See their returns side by side.
Questions
What is the return of Baroda BNP Paribas Health and Wellness Fund?
As of 09 Oct 2026, the direct plan of Baroda BNP Paribas Health and Wellness Fund returned 8.0% over 1 year. The regular plan returned 6.2% over 1 year. Returns over more than a year are annualised.
What is the NAV of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
Baroda BNP Paribas Health and Wellness Fund Direct Growth NAV on 09 Oct 2026: ₹10.4898. Regular Growth NAV: ₹10.2612. NAVs are published by AMFI at the end of each business day.
What is the difference between the direct and regular plan of Baroda BNP Paribas Health and Wellness Fund?
They hold the same portfolio, run by the same manager. The regular plan pays a commission to a distributor each year, so it returned 1.79% less over 1 year.
What is the expense ratio of Baroda BNP Paribas Health and Wellness Fund?
The direct plan of Baroda BNP Paribas Health and Wellness Fund charges 1.51% a year, and the fund manages about ₹487 crore. The regular plan charges more, to pay the distributor's commission. Expense ratios change, so check the fund's latest factsheet.
What are the top holdings of Baroda BNP Paribas Health and Wellness Fund?
As last disclosed, its largest holdings are Sun Pharma.Inds. (8.6%), Torrent Pharma. (7.9%), Divi's Lab. (7.8%), Ipca Labs. (6.1%), Laurus Labs (6.1%). The ten largest make up 58% of the fund, which holds 33 shares in all.
Why is Baroda BNP Paribas Health and Wellness Fund not ranked?
Sector and theme funds are not ranked against each other here, because each follows a different slice of the market. A sector or theme fund is a bet on one part of the economy. Look at how large a part of your portfolio it is, and what would have to go right for it to pay off.
This page is information, not a recommendation to buy, sell or hold any fund. Returns are annualised, for the growth option, from NAVs published by AMFI. A ranking by past return says nothing certain about the future, and the right fund for you depends on your goals and the rest of your portfolio.
Invsify Technologies Private Limited is a SEBI Registered Investment Adviser, Registration No. INA000020572. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Past performance is not indicative of future results.